Showing results (611-620 of 834) with videos related to
Sort By:
Pageof 84
American Journal of Preventive Cardiology|July 6, 2026
Impact of air pollution exposure on chronic kidney disease and type 2 diabetes: A FIDELITY analysisSadeer Al-Kindi, Zhuo Chen, Jean-Eudes Dazard, et al.European Journal of Clinical Investigation|April 24, 2012
Implementation of proteomic biomarkers: making it workHarald Mischak, John P A Ioannidis, Angel Argiles, et al.The Lancet. Diabetes & Endocrinology|March 6, 2020
Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trialNete Tofte, Morten Lindhardt, Katarina Adamova, et al.Journal of Diabetes and Its Complications|February 25, 2023
Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria - A post-hoc analysis of the PRIORITY randomized clinical trialViktor Rotbain Curovic, Nete Tofte, Morten Lindhardt, et al.Diabetic Medicine : a Journal of the British Diabetic Association|January 12, 2021
Non-invasive assessment of temporal changes in myocardial microvascular function in persons with type 2 diabetes and healthy controlsIda K B Rasmussen, Philip Hasbak, Bernt J von Scholten, et al.Diabetes, Obesity & Metabolism|October 4, 2022
Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon-like peptide-1 receptor agonist usePeter Rossing, Rajiv Agarwal, Stefan D Anker, et al.Journal of the American Heart Association|July 19, 2021
Effects of Empagliflozin on Myocardial Flow Reserve in Patients With Type 2 Diabetes Mellitus: The SIMPLE TrialMikkel Jürgens, Morten Schou, Philip Hasbak, et al.Kidney International|May 26, 2026
The Kidney in the Middle: KDIGO Guidelines Address Multiple Key Components of Cardiovascular-Kidney-Metabolic SyndromeAdeera Levin, Nisha Bansal, Ian H de Boer, et al.The Journal of Clinical Endocrinology and Metabolism|April 13, 2026
Combination Treatment for Management of Chronic Kidney Disease and Type 2 Diabetes: A Review and Practical GuidanceMai Mohsen, Tae Won Yi, Labib Faruque, et al.The International Journal of Cardiovascular Imaging|October 20, 2021
Effect of empagliflozin on myocardial structure and function in patients with type 2 diabetes at high cardiovascular risk: the SIMPLE randomized clinical trialMads Ersbøll, Mikkel Jürgens, Philip Hasbak, et al.Pageof 84